Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001819790-25-000027
Filing Date
2025-03-07
Accepted
2025-03-07 16:19:44
Documents
1
Period of Report
2025-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741382377.html 4  
1 FORM 4 wk-form4_1741382377.xml 4 6380
  Complete submission text file 0001819790-25-000027.txt   7810
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Farrow Jeffrey S (Reporting) CIK: 0001405253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 25720367

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)